We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Avacta Group Plc | LSE:AVCT | London | Ordinary Share | GB00BYYW9G87 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
3.75 | 8.33% | 48.75 | 48.00 | 49.50 | 49.00 | 45.00 | 45.00 | 3,936,486 | 12:30:18 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 10.06M | -39.19M | -0.1382 | -3.53 | 138.26M |
Date | Subject | Author | Discuss |
---|---|---|---|
10/12/2018 13:36 | I've come in as well - Good luck - | tomboyb | |
10/12/2018 13:35 | Dave well done for calling this. Where do you see this going? Am I foolish to think this has every right to over 100p? Looks like investors are scrambling to buy in. Perhaps they have just digested we are quite possibly in for a 5 bagger here. The next few hours are going to be big in my opinion but the next few days are going to be bigger. | genierub | |
10/12/2018 13:32 | Looks like you can buy again at 29p but at least it's full offer now and buys are relentless | dave4545 | |
10/12/2018 13:27 | People trying to buy now cannot or have to pay premiums This is a different stock when it has no seller, the mm's will run for cover | dave4545 | |
10/12/2018 13:25 | 500k 880k and 790k About right given the none stop buying today since it dipped to 30p level and lower | dave4545 | |
10/12/2018 13:22 | That’s the 3 big sells out the way, now we know what was holding the price back, onwards and upwards. | 1i1i1i | |
10/12/2018 13:16 | No buy quote online yippee Looks like seller is out | dave4545 | |
10/12/2018 13:15 | Online is a better indication Looks much better now buy close to or at full offer Showing 27p but real bid is 28.1p | dave4545 | |
10/12/2018 12:57 | Level 2 anyone? | herb clark | |
10/12/2018 12:45 | 27.65-27.875p Other mm's happy to bid above mid price for stock, just this one mm with a load of stock to shift. | dave4545 | |
10/12/2018 12:31 | What does upfront mean? Care to define it? When rns confirms that is received you will see next move imo. | babbler | |
10/12/2018 12:28 | I've held this stock a few times. When the mm's have no stock it can rise 3-4p on just 200-300k of buys So it's worth not panicking if you have bought in higher this morning because when the overhang clears the price will race back up | dave4545 | |
10/12/2018 12:14 | If Affirmed are as good as they say then this company can easily reach s billion MC plus more. It really is down to the success on the tech which I believe is ground braking | danatkins | |
10/12/2018 11:57 | Does not say potential in this statementThis multi-target therapeutics development agreement provides upfront and near-term milestone payments, plus longer-term clinical development milestones | babbler | |
10/12/2018 11:56 | The deal is done. The potential is the full amount. They will get a certain amount up front and the rest when they hit milestones. That's the potential. Potential is 315m dollars. | babbler | |
10/12/2018 11:42 | Good news yes. But the big problem with this deal is the word POTENTIAL! ie Jam tomorrow. | lantanatony | |
10/12/2018 11:12 | Yup. Should have waited for my target but happy at 30. For now. Lol. | babbler | |
10/12/2018 11:06 | They are trying to hold the price backWhat happens with next set of news?Massive buy | hampton58 | |
10/12/2018 10:31 | LOL at the MM tactics, holding all the earlier buys back and only now dripping them in, wonder why they want to do that??! | 1i1i1i | |
10/12/2018 09:54 | Nothing wrong with the market here it's just a overhang play. Overhang is winning atm, if the pi's that bought earlier give up you might see 27p levels | dave4545 | |
10/12/2018 09:44 | Avacta Signs Potential $310 Million Pact with LG Chem Life SciencesSource: Dow Jones News By Ian Walker Shares of Avacta Group PLC (AVCT.LN) rose as much as 41% in early trade Monday, its biggest one-day percentage move in more than 12 years, after the company said it has signed a license and partnership agreement with LG Chem Life Sciences that could generate up to $310 million in payments.The developer of the Affimer protein technology--for use in both life-science research and diagnostics assays--said that the agreement provides for upfront and near-term milestone payments, plus longer-term clinical-development milestones totaling $180 million. The company will also receive royalties on any future product sales, and LG Chem will cover Avacta's costs of research and development associated with the collaboration, it said.Avacta also said it may get an additional $130 million in option fees and milestone payments should LG elect to exercise their options for additional targets.Shares at 0835 GMT were up 8.80 pence, or 38%, at 32 pence, having peaked at 37 pence earlier in the session. | 1i1i1i | |
10/12/2018 09:42 | Clues were there in October.We are looking forward to continuing our collaboration to generate more combined products for the research and molecular diagnostic markets.This is a very exciting time for the Group and we look forward to updating the market on continuing commercial progress for Affimer reagents and, importantly, on therapeutic licensing deals." | babbler | |
10/12/2018 09:41 | The market is just jittery over brexit vote tomorrow. Normal day this would have shot up further imo.Who cares about the market believing. Why would a big pharma invest so much if THEY didn't believe. I know which I trust more... | babbler |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions